Loughborough University
Browse

A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies

Download (697.85 kB)
journal contribution
posted on 2017-09-08, 16:00 authored by Benjamin Davies, James Smith, Sarah Rikabi, Karolina Wartolowska, Mark Morrey, Anna French, Robert MacLaren, David Williams, Kim Bure, Rafael Pinedo-Villanueva, Anthony Mathur, Martin Birchall, Evan Snyder, Anthony Atala, Brock Reeve, David Brindley
Cellular therapies, such as stem cell–based treatments, have been widely researched and numerous products and treatments have been developed. Despite this, there has been relatively limited use of these technologies in the healthcare sector. This study sought to investigate the perceived barriers to this more widespread adoption. An anonymous online questionnaire was developed, based on the findings of a pilot study. This was distributed to an audience of clinicians, researchers and commercial experts in 13 countries. The results were analysed for all respondents, and also sub-grouped by geographical region, and by profession of respondents. The results of the study showed that the most significant barrier was manufacturing, with other factors such as efficacy, regulation and cost-effectiveness being identified by the different groups. This study further demonstrates the need for these important issues to be addressed during the development of cellular therapies to enable more widespread adoption of these treatments.

Funding

JS is funded by an MRC UK Studentship.

History

School

  • Mechanical, Electrical and Manufacturing Engineering

Published in

Journal of Tissue Engineering

Volume

8

Pages

204173141772441 - 204173141772441

Citation

DAVIES, B. ... et al, 2017. A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies. Journal of Tissue Engineering, 8, pp. 1-8.

Publisher

SAGE © The Author(s)

Version

  • VoR (Version of Record)

Publisher statement

This work is made available according to the conditions of the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Full details of this licence are available at: http://creativecommons.org/licenses/ by/4.0/

Acceptance date

2017-07-14

Publication date

2017

Notes

This is an Open Access Article. It is published by Sage under the Creative Commons Attribution 4.0 Licence (CC BY). Full details of this licence are available at: http://creativecommons.org/licenses/by/4.0/

ISSN

2041-7314

eISSN

2041-7314

Language

  • en